Drug
Isis 113715
Isis 113715: highest development phase Phase 2, developed by Ionis Pharmaceuticals. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ISIS 113715 NCT00455598 | Phase 2 | Type 2 Diabetes Mellitus |
| ISIS 113715 NCT00330200 | Phase 2 | Type 2 Diabetes Mellitus |
| ISIS 113715 NCT00365781 | Phase 1 | Type 2 Diabetes Mellitus |
Latest
No recent events.
Follow Isis 113715 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.